What the data does support is a reasonable clinical rationale for trying a dual agonist when a single-pathway drug hasn't delivered
If you are still deciding whether a prescription program fits your needs, you can use the free assessment quiz
All compounds supplied at 98% HPLC-verified purity with batch-specific COA documentation
Semaglutide (Wegovy and Ozempic) is FDA-approved for weight loss and blood sugar management, respectively, when used in combination with lifestyle changes such as increased physical activity and a balanced diet
But this pregnancy hormone has found a second life in men's health, specifically for testosterone support and fertility preservation
Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m 2